FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in <i>EGFR</i>-Mutant NSCLC Cells

FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in <i>EGFR</i>-Mutant NSCLC Cells

FGFC1, an active compound isolated from the culture of marine fungi <i>Stachybotrys longispora</i> FG216, elicits fibrinolytic, anti-oxidative, and anti-inflammatory activity. We have previously reported that FGFC1 inhibited the proliferation, migration, and invasion of the non-small cel...

Full description

Bibliographic Details
Main Authors: Jingwen Feng, Songlin Li, Bing Zhang, Namin Duan, Rui Zhou, Shike Yan, Jeevithan Elango, Ning Liu, Wenhui Wu
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Marine Drugs
Subjects:
FGFC1
NSCLC
<i>EGFR</i>-mutant
cell cycle arrest
apoptosis
NF-κB pathway
Online Access:https://www.mdpi.com/1660-3397/20/1/76

Internet

https://www.mdpi.com/1660-3397/20/1/76

Similar Items